These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8672535

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
    Serre V, Dolci W, Schaerer E, Scrocchi L, Drucker D, Efrat S, Thorens B.
    Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effects of glucagon-like peptide-1 (7-36)amide on insulin stimulated rat skeletal muscle glucose transport.
    Hansen BF, Jensen P, Nepper-Christensen E, Skjølstrup B.
    Acta Diabetol; 1998 Jul; 35(2):101-3. PubMed ID: 9747963
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA, O'Harte FP, Harriott P, Mooney MH, Green BD, Flatt PR.
    Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321
    [Abstract] [Full Text] [Related]

  • 48. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.
    Yang H, Egan JM, Wang Y, Moyes CD, Roth J, Montrose MH, Montrose-Rafizadeh C.
    Am J Physiol; 1998 Sep; 275(3):C675-83. PubMed ID: 9730951
    [Abstract] [Full Text] [Related]

  • 49. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.
    Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P.
    Diabetes; 1998 Jan; 47(1):57-65. PubMed ID: 9421375
    [Abstract] [Full Text] [Related]

  • 50. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA.
    Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876
    [Abstract] [Full Text] [Related]

  • 51. Time-dependent stimulation of insulin exocytosis by 3',5'-cyclic adenosine monophosphate in the rat islet beta-cell.
    Yamada S, Komatsu M, Sato Y, Yamauchi K, Kojima I, Aizawa T, Hashizume K.
    Endocrinology; 2002 Nov; 143(11):4203-9. PubMed ID: 12399413
    [Abstract] [Full Text] [Related]

  • 52. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S.
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [Abstract] [Full Text] [Related]

  • 53. Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7-36)amide action in the liver.
    Trapote MA, Clemente F, Galera C, Morales M, Alcántara AI, López-Delgado MI, Villanueva-Peñacarrillo ML, Valverde I.
    J Endocrinol Invest; 1996 Feb; 19(2):114-8. PubMed ID: 8778163
    [Abstract] [Full Text] [Related]

  • 54. Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells.
    Gallwitz B, Schmidt WE, Conlon JM, Creutzfeldt W.
    J Mol Endocrinol; 1990 Aug; 5(1):33-9. PubMed ID: 2168708
    [Abstract] [Full Text] [Related]

  • 55. Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas.
    Fehmann HC, Göke R, Göke B, Arnold R.
    Z Gastroenterol; 1990 Jul; 28(7):348-52. PubMed ID: 2238765
    [Abstract] [Full Text] [Related]

  • 56. Cyclic AMP, a mediator of GLP-1, acts in concert with glucose and tolbutamide to increase cytosolic Ca2+ in pancreatic B-cells.
    Yaekura K, Nakata M, Tanaka H, Yada T.
    Adv Exp Med Biol; 1997 Jul; 426():211-6. PubMed ID: 9544276
    [No Abstract] [Full Text] [Related]

  • 57. Glucagon-like peptide 1 and fatty acids amplify pulsatile insulin secretion from perifused rat islets.
    Cunningham BA, Richard AM, Dillon JS, Daley JT, Civelek VN, Deeney JT, Yaney GC, Corkey BE, Tornheim K.
    Biochem J; 2003 Jan 01; 369(Pt 1):173-8. PubMed ID: 12356335
    [Abstract] [Full Text] [Related]

  • 58. Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function.
    Gros L, Hollande F, Thorens B, Kervran A, Bataille D.
    Eur J Pharmacol; 1995 Feb 15; 288(3):319-27. PubMed ID: 7774676
    [Abstract] [Full Text] [Related]

  • 59. Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle.
    Fürnsinn C, Ebner K, Waldhäusl W.
    Diabetologia; 1995 Jul 15; 38(7):864-7. PubMed ID: 7556991
    [Abstract] [Full Text] [Related]

  • 60. Triggering of insulin release by a combination of cAMP signal and nutrients: an ATP-sensitive K+ channel-independent phenomenon.
    Komatsu M, Sato Y, Yamada S, Yamauchi K, Hashizume K, Aizawa T.
    Diabetes; 2002 Feb 15; 51 Suppl 1():S29-32. PubMed ID: 11815454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.